Zobrazeno 1 - 10
of 206
pro vyhledávání: '"Per, Albertsson"'
Autor:
Per Albertsson, Tom Bäck, Karin Bergmark, Andreas Hallqvist, Mia Johansson, Emma Aneheim, Sture Lindegren, Chiara Timperanza, Knut Smerud, Stig Palm
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
Astatine-211 (211At) has physical properties that make it one of the top candidates for use as a radiation source for alpha particle-based radionuclide therapy, also referred to as targeted alpha therapy (TAT). Here, we summarize the main results of
Externí odkaz:
https://doaj.org/article/d22308bdcbb6401cb0e87576be06c2cb
Autor:
Tom A. Bäck, Karin Jennbacken, Malin Hagberg Thulin, Sture Lindegren, Holger Jensen, Tove Olafsen, Paul J. Yazaki, Stig Palm, Per Albertsson, Jan-Erik Damber, Anna M. Wu, Karin Welén
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Purpose Targeted alpha therapy (TAT) is a promising treatment for micrometastatic and minimal residual cancer. We evaluated systemic α-radioimmunotherapy (α-RIT) of metastatic castration-resistant prostate cancer (mCRPC) using the α-parti
Externí odkaz:
https://doaj.org/article/cb79622cfe444d258013759e1047e094
Autor:
Stig Palm, Tom Bäck, Emma Aneheim, Andreas Hallqvist, Ragnar Hultborn, Lars Jacobsson, Holger Jensen, Sture Lindegren, Per Albertsson
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100873- (2021)
Introduction: Antibodies labeled with alpha-emitter astatine-211 have previously shown effective in intraperitoneal (i.p.) treatments of ovarian cancer. In the present work we explore the use of investigational farletuzumab, aimed at the folate recep
Externí odkaz:
https://doaj.org/article/8b5b24b491734c9ea4620f2acfedf29f
Autor:
Sebastian Völz, Petur Petursson, Jacob Odenstedt, Dan Ioanes, Inger Haraldsson, Oskar Angerås, Christian Dworeck, Geir Hirlekar, Anna Myredal, Per Albertsson, Truls Råmunddal, Björn Redfors, Elmir Omerovic
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 14 (2020)
Background Ticagrelor reduces ischaemic end points in acute coronary syndromes. However, outcomes of ticagrelor versus clopidogrel in real‐world patients with acute coronary syndromes treated with percutaneous coronary intervention (PCI) remain unc
Externí odkaz:
https://doaj.org/article/fc1a7d7a57e3432ea9858db8f0ad4edc
Autor:
Geir Hirlekar, Martin Jonsson, Thomas Karlsson, Jacob Hollenberg, Per Albertsson, Johan Herlitz
Publikováno v:
Data in Brief, Vol 21, Iss , Pp 1541-1551 (2018)
The data presented in this article is supplementary to the research article titled ”Comorbidity and survival in out-of-hospital cardiac arrest” (Hirlekar et al., 2018).The data contains information of how Charlson Comorbidity Index (CCI) is calcu
Externí odkaz:
https://doaj.org/article/7ee0972b87bf4430b8eb119fcc129e4c
Autor:
Kristina Levan, Matin Mehryar, Constantina Mateoiu, Per Albertsson, Tom Bäck, Karin Sundfeldt
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background To characterize the expression of the membrane transporter NaPi2b and antigen targeted by the MX35 antibody in ovarian tumor samples. The current interest to develop monoclonal antibody based therapy of ovarian cancer by targeting
Externí odkaz:
https://doaj.org/article/ca8b19a5b23c401c858393a571d362c1
Autor:
Anna Gustafsson-Lutz, Tom Bäck, Emma Aneheim, Ragnar Hultborn, Stig Palm, Lars Jacobsson, Alfred Morgenstern, Frank Bruchertseifer, Per Albertsson, Sture Lindegren
Publikováno v:
EJNMMI Research, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract Background The aim of this study was to compare the therapeutic efficacy of two different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model. Sixty female BALB/c (nu/nu) mice were inoculated intraperiton
Externí odkaz:
https://doaj.org/article/9db342e805264a548da9e9feb6f45337
Autor:
Erik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm, Per Albertsson
Publikováno v:
Journal of Nuclear Medicine. 64:165-172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5e113eea8983958e0887526a1dde657
https://doi.org/10.2967/jnumed.121.263349
https://doi.org/10.2967/jnumed.121.263349
Autor:
Charlotte Palmqvist, Hanna Michaëlsson, Christian Staf, Mia Johansson, Per Albertsson, Pernilla Dahm‐Kähler
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 101:747-757
Surgical complications after primary or interval debulking surgery in advanced ovarian cancer were investigated and associations with patient characteristics and surgical outcomes were explored.A population-based cohort study including all women with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e6c7c7a70199b12c39f48059422802
https://doi.org/10.1111/aogs.14355
https://doi.org/10.1111/aogs.14355
Publikováno v:
Acta oncologica (Stockholm, Sweden). 61(11)
The societal cost associated with ovarian cancer (OC) is not well known. Increasing costs for new treatments and/or the impact of organizational changes motivates these costs to be described and communicated. This study aims to evaluate the cost of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2359f5f8836b39318119ffa6a1110c70
https://pubmed.ncbi.nlm.nih.gov/36326583
https://pubmed.ncbi.nlm.nih.gov/36326583